Pluri (PLUR) Gross Profit Growth (1y) (2012 - 2025)
Pluri (PLUR) Gross Profit Growth (1y) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
75.94% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
7.76% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Pluri |
20.93 Mn |
21.41 Mn |
86,000.00 |
-22.52% |
| Date | Value |
|---|
| Dec 31, 2025 |
-22.52% |
| Sep 30, 2025 |
-42.50% |
| Jun 30, 2025 |
125.00% |
| Mar 31, 2025 |
91.55% |
| Dec 31, 2024 |
5.71% |
| Sep 30, 2024 |
270.37% |
| Dec 31, 2019 |
-54.17% |
| Dec 31, 2018 |
0.00% |
| Dec 31, 2015 |
2,817.58% |
| Sep 30, 2015 |
0.00% |
| Dec 31, 2014 |
-1.09% |
| Sep 30, 2014 |
0.00% |
| Jun 30, 2014 |
-1.08% |
| Mar 31, 2014 |
-51.06% |
| Dec 31, 2013 |
-51.32% |
| Sep 30, 2013 |
-51.32% |
| Jun 30, 2013 |
-5.10% |
| Mar 31, 2013 |
-16.07% |
| Dec 31, 2012 |
84,275.00% |
| Sep 30, 2012 |
26.85% |
